The current study combines data from five clinical trials involving a total of 1,287 people, including the SWIFT PRIME trial led by Saver, that show these devices improved outcomes for people with acute
ischemic strokes due to large vessel blockage.
Not exact matches
«Our research has identified a gene affecting another type of
ischemic stroke,
due to small vessel disease, and also suggests some genes may be associated with both
ischemic and hemorrhagic
stroke and may act through a novel pathway affecting pericytes, a type of cell in the wall of small arteries and capillaries.
1,680
strokes were documented: 1,310
ischemic strokes / cerebral infarctions (
due to blockages), 79 subarachnoid hemorrhages (
due to bleeding on the brain surface), 154 intracerebral hemorrhages (
due to bleeding in the brain), as well as 137 unspecified
strokes.
The risk of
stroke dramatically increases in the days following an attack, and the transient
ischemic attack could present a chance to minimize the risk or find a cause in order to prevent the permanent neurologic damage that results
due to a
stroke.
This can include an
ischemic stroke, hemorrhagic
stroke or bleeding
due to an aneurysm.